From the Journals

Breath test may detect esophagogastric cancer


 

FROM JAMA ONCOLOGY

The authors noted that with fecal occult blood testing and the Cytosponge test, multiple episodes of testing were known to increase the sensitivity, so this could be another area for future research in breath testing.

The breath test was seen as something that could be used in primary care to identify patients with nonspecific symptoms who should be referred for endoscopy.

“This view has been endorsed by our recent finding that the diagnostic model for OGC [oesophagogastric cancer] is different from that for colorectal cancer, providing the concept for a single breath test for multiple gastrointestinal cancers,” the authors wrote.

“If a clinician is presented with a patient with gastrointestinal symptoms that do not prompt referral based on NICE [National Institute for Health and Care Excellence] criteria, he/she would not need to watch and wait to see if symptoms worsen but could offer the exhaled breath test immediately.”

Recommended Reading

Alpha fetoprotein boosted detection of early-stage liver cancer
MDedge Hematology and Oncology
Bevacizumab-awwb becomes first biosimilar approved for cancer treatment
MDedge Hematology and Oncology
MDedge Daily News: Is ‘medical aid in dying’ suicide?
MDedge Hematology and Oncology
MDedge Daily News: Fewer smokes mean fewer strokes
MDedge Hematology and Oncology
MDedge Daily News: How to handle opioid constipation
MDedge Hematology and Oncology
New drugs provide new options in HCC
MDedge Hematology and Oncology
Patients with CF at increased risk for GI cancers
MDedge Hematology and Oncology
Advanced adenoma on colonoscopy linked to increased colorectal cancer incidence
MDedge Hematology and Oncology
Is cancer immunotherapy more effective in men than women?
MDedge Hematology and Oncology
Intraperitoneal chemo missed main endpoint, yet may benefit gastric cancer
MDedge Hematology and Oncology